Knowledge Hub

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023

Press release   •   Feb 03, 2017 04:37 EST has recently announced the addition of a market study “ Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023”, is a comparative analysis of the global market.

DelveInsights Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Acute Myeloid Leukemia (AML) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Acute Myeloid Leukemia (AML) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Acute Myeloid Leukemia (AML) till 2023.

Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Acute Myeloid Leukemia (AML) market.

Identifying patient populations in the global Acute Myeloid Leukemia (AML) market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Acute Myeloid Leukemia (AML) therapeutics in each of the markets covered.

To understand the future market competition in the global Acute Myeloid Leukemia (AML) therapeutics market and Insightful review of the key market drivers and barriers.


Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

Download The sample Copy Of This Report:

The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

It also provides Acute Myeloid Leukemia (AML) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Table Of Content

Acute Myeloid Leukemia (AML) overview


Symptoms of disease

Etiology of disease

Diagnosis of disease

Treatment of disease

Overview of Marketed drugs

Drug Description

Mechanism of Action

Pharmacokinetics Properties

Marketed Details

Patent Information

Patent Exclusivity Expiry Assessment United States (US)

Patents Details

Historical and Forecasted sales of marketed molecules in the Global Acute Myeloid Leukemia (AML) Market

Global Epidemiology of Acute Myeloid Leukemia (AML) Forecasted to 2023

Global Market (2013-2015)

Global Forecasted Market (2016-2023)

Global Market by Geography

Market of US (2013-2015)

Forecasted Market of US (2016-2023)

Market of Europe

Market of Germany (2013-2015)

Forecasted Market of Germany (2016-2023)

Market of United Kingdom (2013-2015)

Forecasted Market of United Kingdom (2016-2023)

Market of France (2013-2015)

Forecasted Market of France (2016-2023)

Market of Italy (2013-2015)

Forecasted Market of Italy (2016-2023)

Market of Spain (2013-2015)

Forecasted Market of Spain (2016-2023)

Market of Japan (2013-2015)

Forecasted Market of Japan (2016-2023)

Market of ROW (2013-2015)

Forecasted Market of ROW (2016-2023)


Report Methodology

Consulting Services


Report Purchase Options

About DelveInsight